The U.S. Department of Justice is looking into accusations leveled against cardiologist Dr. Elie Hage Korban and two Tennessee hospitals, alleging that they ran a scheme to defraud government insurance programs through overuse of medical services.
The accuser is fellow Tennessee cardiologist Dr. Wood Deming, who claims Korban falsely dictated symptoms in heart patients to authorize medical procedures for reimbursement by government programs.
Deming also points the finger at executives at Jackson-Madison County General Hospital and the Regional Hospital of Jackson as well as radiologist Dr. Joel Perchik for condoning or abetting Korban’s alleged fraud and for engaging in kick-back schemes.
Health Benefit Consultants, Share Your Expert Insights in Our Survey
MassDevice Staff Website The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
The whistleblower claims hospital executives allowed Korban to order unnecessary diagnostic studies at the hospitals where the patients were then transported for additional unnecessary procedures, Heartwire reported.
Deming further alleges that the hospitals’ leadership attacked physicians who tried to oppose the scheme, giving them bad-faith peer reviews leading to their elimination from the medical staff.
The investigation joins other cases surrounding overuse of stenting. In January 2010 the Baltimore-based St. Joseph Medical Center notified 369 patients who received coronary stents under the care of Dr. Mark Midei that the implants may not have been needed, which resulted in a class action lawsuit.
St. Joseph’s settled without admitting guilt in November of last year, paying a fine of $22 million.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
